| __timestamp | Amicus Therapeutics, Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 1643000000 |
| Thursday, January 1, 2015 | 47269000 | 1532000000 |
| Friday, January 1, 2016 | 71151000 | 1364000000 |
| Sunday, January 1, 2017 | 88671000 | 1334000000 |
| Monday, January 1, 2018 | 127200000 | 1484000000 |
| Tuesday, January 1, 2019 | 169861000 | 1638000000 |
| Wednesday, January 1, 2020 | 156407000 | 1726000000 |
| Friday, January 1, 2021 | 192710000 | 2001000000 |
| Saturday, January 1, 2022 | 213041000 | 2009000000 |
| Sunday, January 1, 2023 | 275270000 | 2151000000 |
| Monday, January 1, 2024 | 2318000000 |
Igniting the spark of knowledge
In the competitive landscape of the pharmaceutical industry, understanding the financial strategies of leading companies is crucial. Over the past decade, Zoetis Inc. and Amicus Therapeutics, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Zoetis Inc. consistently maintained higher SG&A expenses, peaking at approximately $2.15 billion in 2023, reflecting a strategic investment in market expansion and operational efficiency. In contrast, Amicus Therapeutics, Inc. exhibited a steady increase, with expenses rising from $20 million in 2014 to $275 million in 2023, marking a significant growth of over 1,200%. This divergence highlights Zoetis's established market presence and Amicus's aggressive growth strategy. As the industry evolves, these financial patterns offer insights into each company's priorities and potential future trajectories.
Cost Management Insights: SG&A Expenses for Bristol-Myers Squibb Company and Amicus Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and argenx SE
Who Optimizes SG&A Costs Better? Zoetis Inc. or Opthea Limited
Breaking Down SG&A Expenses: Zoetis Inc. vs Xenon Pharmaceuticals Inc.
Comparing SG&A Expenses: Zoetis Inc. vs Perrigo Company plc Trends and Insights
Selling, General, and Administrative Costs: Zoetis Inc. vs Wave Life Sciences Ltd.
Comparing SG&A Expenses: Viatris Inc. vs Amicus Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs Amicus Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Viking Therapeutics, Inc. or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Amicus Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Amicus Therapeutics, Inc. and Novavax, Inc.